nach oben

International Journal of Diabetes in Developing Countries

Erschienen in:

04.06.2020 | COVID-19 | Editorial Zur Zeit gratis

Post COVID-19 diabetes care—lessons and challenges

verfasst von: S. V. Madhu

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Excerpt

The outbreak of COVID-19 all over the world this year has posed several new challenges to diabetes care and has also provided an opportunity for new lessons to be learnt in what seems to be transforming the way we treat diabetic patients. …

Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14:303–10.CrossRef

Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020;14:211–2.CrossRef

Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J Clin Virol. 2020;127:104354.CrossRef

Pal R, Bhansali A. COVID-19, diabetes mellitus and ACE2: the conundrum. Diabetes Res Clin Pract. 2020;162:108132.CrossRef

Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020. https://doi.org/10.1016/S2213-8587(20)30152-2.

Pal R, Bhadada SK. Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? Diabetes Res Clin Pract. 2020;163:108146.CrossRef

Carboni E, Carta AR, Carboni E. Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19? Med Hypotheses. 2020;140:109776. https://doi.org/10.1016/j.mehy.2020.109776 Epub ahead of print.CrossRefPubMedPubMedCentral

Singh AK, Singh A, Shaikh A, Singh R, Misra A. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: a systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab Syndr. 2020;14(3):241–6.CrossRef

Castiglione V, Chiriacò M, Emdin M, Taddei S, Vergaro G. Statin therapy in COVID-19 infection. Eur Heart J Cardiovasc Pharmacother. 2020. https://doi.org/10.1093/ehjcvp/pvaa042.

Titel: Post COVID-19 diabetes care—lessons and challenges
verfasst von: S. V. Madhu
Publikationsdatum: 04.06.2020
Verlag: Springer India
Schlagwort: COVID-19
Erschienen in: International Journal of Diabetes in Developing Countries / Ausgabe 2/2020
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-020-00831-6

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

The relationship between insulin resistance, obesity, and endotrophin

Association of Cornell product with metabolic syndrome in middle-aged people in China

A systematic review of the effect of sleep apnea syndrome and its therapy on HbA1c in type 2 diabetes

Correction to: The role of osteocalcin in mechanism of steroid induced diabetes mellitus

Association of adiponectin gene polymorphisms and their haplotypes with type 2 diabetes and related metabolic traits in an Iranian population

Quality of metabolic control, serum potassium, and aging are the major determinants of severity of musculoskeletal disorders in hospitalized diabetic patients